Neurocrine UK Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 13

Neurocrine UK General Information

Description

Developer of physiological hormone replacement products designed to aid lifelong treatment for rare and chronic diseases. The company is a pharmaceutical firm focused on chronic endocrine conditions.

Contact Information

Formerly Known As
Diurnal Group, Diurnal
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Cardiff Medicentre
  • Heath Park
  • Cardiff CF14 4UJ
  • Wales, United Kingdom
+44 029
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Cardiff Medicentre
  • Heath Park
  • Cardiff CF14 4UJ
  • Wales, United Kingdom
+44 029

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurocrine UK Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neurocrine UK‘s full profile, request access.

Request a free trial

Neurocrine UK Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurocrine UK Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neurocrine UK‘s full profile, request access.

Request a free trial

Neurocrine UK FAQs

  • When was Neurocrine UK founded?

    Neurocrine UK was founded in 2004.

  • Where is Neurocrine UK headquartered?

    Neurocrine UK is headquartered in Cardiff, United Kingdom.

  • What is the size of Neurocrine UK?

    Neurocrine UK has 51 total employees.

  • What industry is Neurocrine UK in?

    Neurocrine UK’s primary industry is Drug Delivery.

  • Is Neurocrine UK a private or public company?

    Neurocrine UK is a Private company.

  • What is the current valuation of Neurocrine UK?

    The current valuation of Neurocrine UK is .

  • What is Neurocrine UK’s current revenue?

    The current revenue for Neurocrine UK is .

  • How much funding has Neurocrine UK raised over time?

    Neurocrine UK has raised $91.5M.

  • Who are Neurocrine UK’s investors?

    Development Bank of Wales, FusionIP, IP Group, Neurocrine Biosciences, and SIMM INVESTMENTS are 5 of 7 investors who have invested in Neurocrine UK.

  • When was Neurocrine UK acquired?

    Neurocrine UK was acquired on 21-Jan-2026.

  • Who acquired Neurocrine UK?

    Neurocrine UK was acquired by Immedica Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process